SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000812796-05-000024
Filing Date
2005-11-14
Accepted
2005-11-14 16:32:10
Documents
6
Period of Report
2005-11-14

Document Format Files

Seq Description Document Type Size
1 DOR 3Q 2005 dor3q05.htm 10QSB 383847
2 CEO CERT 302 3Q 2005 ceocert-3q05.htm EX-31.1 12019
3 CFO CERT 302 3Q 05 cfocert3q05.htm EX-31.2 12017
4 CEO CERT 906 3Q05 ceo906-3q05.htm EX-32.1 5900
5 CFO CERT 906 3Q 05 cfocert906-3q05.htm EX-32.2 5783
6 RISK FACTORS 3Q 2005 riskfactors3q05.htm EX-99.1 71498
  Complete submission text file 0000812796-05-000024.txt   492672
Mailing Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139
Business Address 1691 MICHIGAN AVE. SUITE 435 MIAMI FL 33139 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 051202029
SIC: 2834 Pharmaceutical Preparations